General Information of the Compound
| Compound ID |
CP0504194
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,5S,8S,12S)-5,8-dibenzyl-2-(1H-indol-3-ylmethyl)-12-(2-morpholin-4-yl-2-oxoethyl)-1,4,7,10-tetrazacyclotetradecane-3,6,11,14-tetrone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H44N6O6
|
||||||||||||||||||
| Molecular Weight |
692.817
|
||||||||||||||||||
| Canonical SMILES |
O=C(C[C@@H]1CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)CNC1=O)N1CCOCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H44N6O6/c46-35-22-28(23-36(47)45-15-17-51-18-16-45)37(48)41-25-30(19-26-9-3-1-4-10-26)42-38(49)33(20-27-11-5-2-6-12-27)44-39(50)34(43-35)21-29-24-40-32-14-8-7-13-31(29)32/h1-14,24,28,30,33-34,40H,15-23,25H2,(H,41,48)(H,42,49)(H,43,46)(H,44,50)/t28-,30-,33-,34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFVKJEFFJVAPHY-PMPXORTOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound